Related references
Note: Only part of the references are listed.Successful treatment with adalimumab in a familial case of gastrointestinal Behcet's disease
Chiara De Cassan et al.
JOURNAL OF CROHNS & COLITIS (2011)
Efficacy of combination therapy of anti-TNF-α antibody infliximab and methotrexate in refractory entero-Beh‡et's disease
Shigeru Iwata et al.
MODERN RHEUMATOLOGY (2011)
Successful switching to adalimumab in an infliximab-allergic patient with severe Beh‡et disease-related uveitis
Kaoru Takase et al.
RHEUMATOLOGY INTERNATIONAL (2011)
Late response to anti-TNF-α therapy in refractory mucocutaneous lesions of Beh‡et's disease
Nadia Emi Aikawa et al.
RHEUMATOLOGY INTERNATIONAL (2011)
Anti-TNF Agents for Behcet's Disease: Analysis of Published Data on 369 Patients
Aikaterini Arida et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2011)
Treat early and embrace the evidence in favour of anti-TNF-alpha therapy for Behcet's uveitis
Richard W. J. Lee et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2010)
Adalimumab treatment for life threatening pulmonary artery aneurysm in Behcet disease: a case report
Sung-Won Lee et al.
CLINICAL RHEUMATOLOGY (2010)
Clinical Experience with Adalimumab in the Treatment of Ocular Behcet Disease
Ahmed Bawazeer et al.
OCULAR IMMUNOLOGY AND INFLAMMATION (2010)
Effects of infliximab in the treatment of refractory posterior uveitis of Behçet’s disease after withdrawal of infusions
Alfredo Adán et al.
INTERNATIONAL OPHTHALMOLOGY (2010)
Management of Behcet disease: a systematic literature review for the European League Against Rheumatism evidence-based recommendations for the management of Behcet disease
G. Hatemi et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Effects of anti-TNF- antibody infliximab in refractory entero-Behets disease
Shigeru Iwata et al.
RHEUMATOLOGY (2009)
EULAR recommendations for the management of Behcet disease
G. Hatemi et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
Adalimumab en el tratamiento de la enfermedad de Behçet
José Luis Callejas-Rubio et al.
MEDICINA CLINICA (2008)
Adalimumab for sight-threatening uveitis in Behcet's disease
B. Mushtaq et al.
EYE (2007)
Anti-TNF therapy in the management of Behcet's disease - review and basis for recommendations
P. P. Sfikakis et al.
RHEUMATOLOGY (2007)
Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop
DA Jabs et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2005)
Ocular involvement in Behcet's disease:: first 5-year-results for visual development after treatment with interferon alfa-2a
CME Deuter et al.
OPHTHALMOLOGE (2004)
Human recombinant interferon alfa-2a for the treatment of Behcet's disease with sight threatening posterior or panuveitis
I Kötter et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2003)
Behcet's ileocolitis: Successful treatment with tumor necrosis factor-alpha antibody (infliximab) therapy - Report of a case
MT Kram et al.
DISEASES OF THE COLON & RECTUM (2003)
Interferon alfa-2a in the treatment of Behcet disease - A randomized placebo-controlled and double-blind study
E Alpsoy et al.
ARCHIVES OF DERMATOLOGY (2002)
Serum levels of TNF-α, sIL-2R, IL-6, and IL-8 are increased and associated with elevated lipid peroxidation in patients with Behcet's disease
C Evereklioglu et al.
MEDIATORS OF INFLAMMATION (2002)
Treatment of intestinal Behcet's syndrome with chimeric tumour necrosis factor α antibody
SPL Travis et al.
GUT (2001)
Interferon-alpha 2a treatment of neuro-Behcet disease
JC Nichols et al.
JOURNAL OF NEURO-OPHTHALMOLOGY (2001)
Share Paper
